Noronex Ltd. ( (AU:NRX) ) has provided an update.
Noronex Ltd. has released its interim financial report for the half-year ending December 31, 2024. The report includes various financial statements such as the condensed consolidated statement of profit or loss, financial position, changes in equity, and cash flows, along with notes to the interim consolidated financial statements. This release provides insights into the company’s financial health and operational performance, which are crucial for stakeholders to assess the company’s market positioning and future prospects.
More about Noronex Ltd.
YTD Price Performance: 60.0%
Average Trading Volume: 1,521,188
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$7.5M
See more data about NRX stock on TipRanks’ Stock Analysis page.